Related Experiment Video
Updated: Dec 23, 2025

04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
15.0K
Superiority Claims for Spinal Devices: A Systematic Review of Randomized Controlled Trials
S Raymond Golish1, Michael W Groff2, Ali Araghi3
1Jupiter Medical Center, Palm Beach, FL, USA.
Global Spine Journal
|April 22, 2020
Summary
Many spinal device trials make superiority claims based on noninferiority studies, but these claims often carry a high risk of bias. Careful evaluation of bias is crucial for healthcare decision-makers when interpreting these findings.
Area of Science:
- Biomedical Engineering
- Clinical Trials
- Medical Device Research
Background:
- Superiority claims for medical devices are frequently based on noninferiority trials, posing interpretation challenges.
- Understanding the prevalence and validity of these claims is essential for evidence-based healthcare decisions.
Purpose of the Study:
- To determine the proportion of noninferiority and superiority designs in spinal device trials.
- To assess how often superiority claims arise post hoc from noninferiority studies.
- To critically evaluate the risk of bias associated with these superiority claims.
Main Methods:
- A systematic review of spinal device trials was conducted.
- The Cochrane Risk of Bias Tool was employed to assess study bias.
- Risk of bias for superiority claims was evaluated based on hypothesis specification, population analysis, outcome modification, and sensitivity analyses.
Main Results:
- Of 41 trials, 46% were noninferiority, 37% were noninferiority with secondary superiority hypotheses, and 17% were superiority trials.
- 14 (41%) of noninferiority trials made superiority claims, with 64% of these having medium or high risk of bias.
- Superiority claims in noninferiority trials were frequently associated with issues like analyzed population, sensitivity analyses, and modified endpoints.
Conclusions:
- Healthcare decision-makers must rigorously assess the risk of bias in superiority claims derived from spinal device trials.
- Conclusions drawn from noninferiority trials with post hoc superiority claims require cautious interpretation due to potential bias.

